Fig. 6: Identification of GRP75 as a characteristic cancer-promoting factor and the clinical significance of GRP75 in GC.

A and B H&E, IHC staining, and IHC-intensity of GRP75 in tumors and adjacent tissues. C and D IHC staining and IHC-intensity of GRP75 in different TNM stages. E IHC staining of GRP75 in tumors with low and high levels. F The transverse diameters of tumors in GRP75 low and high groups. G Kaplan-Meier analysis of the prognostic significances of GRP75 in these samples.